High dose chemotherapy and autologous stem cell transplantation for metastatic breast cancer: is there a place?

被引：0
作者：
Stadtmauer, EA [1 ]
机构：
[1] Univ Penn, Ctr Canc, Bone Marrow & Stem Cell Transplant Program, Philadelphia, PA 19104 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 81卷
关键词：
high dose chemotherapy; metastatic breast cancer; stem cell transplant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Seven comparative trials with over 2000 patients enrolled show no definitive evidence that high dose chemotherapy with stem cell support offers a survival advantage for metastatic breast cancer over conventional dose chemotherapy. Though numbers are low and small differences may exist particularly in subsets of patients, the duration of follow-up is adequate to make the likelihood of a late benefit low. High dose chemotherapy with stem cell transplantation does not have a place in the treatment of metastatic breast cancer outside of clinical trials.
引用
收藏
页码：S111 / S115
页数：5
相关论文
共 50 条
  • [31] High-dose chemotherapy with autologous stem cell rescue for breast cancer: Yesterday, today and tomorrow
    Brockstein, BE
    Williams, SF
    STEM CELLS, 1996, 14 (01) : 79 - 89
  • [32] Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer
    Wong, R
    Rondon, G
    Saliba, RM
    Shannon, VR
    Giralt, SA
    Champlin, RE
    Ueno, NT
    BONE MARROW TRANSPLANTATION, 2003, 31 (12) : 1157 - 1163
  • [33] High-dose chemotherapy with peripheral blood stem cell transplantation in breast cancer management
    Jentsch-Ullrich, K
    Höffken, HG
    Franke, A
    ZENTRALBLATT FUR CHIRURGIE, 1998, 123 : 162 - 164
  • [34] High-dose chemotherapy and autologous stem cell transplantation for pediatric brain tumors
    Lee, Soo Hyun
    Sung, Ki Woong
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2012, 55 (05): : 430 - 437
  • [35] High-dose chemotherapy and autologous stem cell transplantation in treating paediatric malignancies
    Valteau-Couanet, D.
    Dufour, C.
    Hartmann, O.
    ONCOLOGIE, 2007, 9 (12) : 827 - 831
  • [36] Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation:: Implications for patient selection
    Montemurro, F
    Rondón, G
    Munsell, M
    Smith, TL
    Donato, ML
    Gajewski, JL
    Rabman, ZU
    Buzdar, AU
    Champlin, RE
    Ueno, NT
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (05) : 330 - 340
  • [37] High-dose chemotherapy with mitoxantrone plus melphalan and autologous stem cell rescue in metastatic breast cancer patients: A study of feasibility and tolerability
    Martino, M
    Morabito, F
    Console, G
    Irrera, G
    Pucci, G
    Penna, G
    Dattola, A
    Callea, I
    Pontari, A
    Condemi, A
    Messina, G
    Nardi, M
    Cicero, G
    Molica, S
    Palazzo, S
    Iacopino, P
    TUMORI, 2003, 89 (05) : 492 - 496
  • [38] Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit
    Kurian, Sobha
    Qazilbash, Muzzafar
    Fay, Joseph
    Wolff, S.
    Herzig, Roger
    Hobbs, Gerry
    Bunner, Pam
    Weisenborn, Robin
    Aya-ay, Melanie
    Lynch, Joseph
    Ericson, Solveig
    BREAST JOURNAL, 2006, 12 (06) : 531 - 535
  • [39] Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation
    Dimeo, FC
    Tilmann, MHM
    Bertz, H
    Kanz, L
    Mertelsmann, R
    Keul, J
    CANCER, 1997, 79 (09) : 1717 - 1722
  • [40] Is there a role of high dose chemotherapy and autologous stem cell transplantation in the treatment of Ewing's sarcoma and osteosarcomas?
    Karadurmus, Nuri
    Sahin, Ugur
    Basgoz, Bilgin Bahadir
    Demirer, Taner
    JOURNAL OF BUON, 2018, 23 (05): : 1235 - 1241
12345